Alaska Permanent Fund’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,624
| Closed | -$2.77M | – | 353 |
|
|
2025
Q1 | $2.77M | Hold |
4,624
| – | – | 0.04% | 201 |
|
|
2024
Q4 | $3.29M | Hold |
4,624
| – | – | 0.05% | 172 |
|
|
2024
Q3 | $4.86M | Hold |
4,624
| – | – | 0.07% | 113 |
|
|
2024
Q2 | $4.99M | Buy |
4,624
+720
| +18% | +$777K | 0.07% | 114 |
|
|
2024
Q1 | $3.76M | Buy |
3,904
+58
| +2% | +$55.8K | 0.06% | 130 |
|
|
2023
Q4 | $3.38M | Buy |
3,846
+1,641
| +74% | +$1.44M | 0.06% | 128 |
|
|
2023
Q3 | $1.81M | Buy |
2,205
+1,720
| +355% | +$1.42M | 0.03% | 312 |
|
|
2023
Q2 | $348K | Buy |
+485
| New | +$348K | 0.01% | 361 |
|
|
2022
Q4 | $267K | Buy |
370
+2
| +0.5% | +$1.44K | ﹤0.01% | 325 |
|
|
2022
Q3 | $253K | Buy |
368
+58
| +19% | +$39.9K | ﹤0.01% | 319 |
|
|
2022
Q2 | $183K | Sell |
310
-4,838
| -94% | -$2.86M | ﹤0.01% | 322 |
|
|
2022
Q1 | $3.6M | Sell |
5,148
-18
| -0.3% | -$12.6K | 0.06% | 44 |
|
|
2021
Q4 | $3.14M | Buy |
5,166
+166
| +3% | +$101K | 0.06% | 43 |
|
|
2021
Q3 | $3.03M | Hold |
5,000
| – | – | 0.06% | 46 |
|
|
2021
Q2 | $2.79M | Buy |
+5,000
| New | +$2.79M | 0.05% | 37 |
|